Measured Wealth Private Client Group, LLC Gilead Sciences, Inc. Transaction History
Measured Wealth Private Client Group, LLC
- $330 Million
- Q2 2025
A detailed history of Measured Wealth Private Client Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 2,072 shares of GILD stock, worth $249,613. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,072
Previous 2,083
0.53%
Holding current value
$249,613
Previous $233,000
1.72%
% of portfolio
0.07%
Previous 0.08%
Shares
13 transactions
Others Institutions Holding GILD
# of Institutions
2,340Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.13 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.58 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.52 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $151B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...